<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Inter Press ServiceIf clinical trials are successful, the new tenofovir microbicide gel that protects women against the HIV virus will be manufactured in South Africa.</title>
	<atom:link href="https://www.ipsnews.net/2011/06/if-clinical-trials-are-successful-the-new-tenofovir-microbicide-gel-that-protects-women-against-the-hiv-virus-will-be-manufactured-in-south-africa/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.ipsnews.net/2011/06/if-clinical-trials-are-successful-the-new-tenofovir-microbicide-gel-that-protects-women-against-the-hiv-virus-will-be-manufactured-in-south-africa/</link>
	<description>News and Views from the Global South</description>
	<lastBuildDate>Mon, 18 May 2026 17:52:25 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.8.3</generator>
		<item>
		<title>If clinical trials are successful, the new tenofovir microbicide gel that protects women against the HIV virus will be manufactured in South Africa.</title>
		<link>https://www.ipsnews.net/2011/06/if-clinical-trials-are-successful-the-new-tenofovir-microbicide-gel-that-protects-women-against-the-hiv-virus-will-be-manufactured-in-south-africa/</link>
		<comments>https://www.ipsnews.net/2011/06/if-clinical-trials-are-successful-the-new-tenofovir-microbicide-gel-that-protects-women-against-the-hiv-virus-will-be-manufactured-in-south-africa/#respond</comments>
		<pubDate>Mon, 20 Jun 2011 17:45:01 +0000</pubDate>
		<dc:creator>IPS Correspondents</dc:creator>
				<category><![CDATA[Multimedia]]></category>
		<category><![CDATA[Podcast]]></category>

		<guid isPermaLink="false">http://ipsnews.zippykid.it/?p=102616</guid>
		<description><![CDATA[Dr Henry Gabelnick, of CONRAD, says licensing makes it possible to produce the topical gel to fit in to several price structures. Tinus de Jager asked Gabelnick what rights the South Africans received. [podcast]http://traffic.libsyn.com/ipsaudio/20110620_conrad_dejagert.mp3[/podcast]]]></description>
		
			<content:encoded><![CDATA[<p><font color="#999999"><img width="200" height="139" src="https://www.ipsnews.net/Library/2012/01/tubes_.jpg" class="attachment-medium size-medium wp-post-image" alt="" decoding="async" /></font></p><p>By IPS Correspondents<br />Jun 20 2011 (IPS) </p><p>Dr Henry Gabelnick, of CONRAD, says licensing makes it possible to produce the topical gel to fit in to several price structures. Tinus de Jager asked Gabelnick what rights the South Africans received.</p>
<p><span id="more-102616"></span></p>
<p>[podcast]http://traffic.libsyn.com/ipsaudio/20110620_conrad_dejagert.mp3[/podcast]</p>
		]]></content:encoded>
			<wfw:commentRss>https://www.ipsnews.net/2011/06/if-clinical-trials-are-successful-the-new-tenofovir-microbicide-gel-that-protects-women-against-the-hiv-virus-will-be-manufactured-in-south-africa/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
<enclosure url="http://traffic.libsyn.com/ipsaudio/20110620_conrad_dejagert.mp3" length="2311725" type="audio/mpeg" />
		</item>
	</channel>
</rss>
